Orange County NC Website
~~ <br />4 Clusters of rare cancers. Because lung, breast, colon, and prostate cancers are so common, it <br />is very difficult to find any association between them and exposures in a community. <br />These analyses are done on a tiered basis, starting with the county rates, to ensure stable rates and to <br />identify potential cancer sites or age groups of concern, The results of this analysis were used to focus <br />on the smaller study area, in particular, the Mill Creek Area of Orange County, <br />Geographic Analysis <br />Delineation of a study area was a central focus of this study.. A primary concern to some homeowners <br />is the incidence of naturally occurring arsenic in wells. Because not all privately maintained wells in <br />Orange County or in the Mill Creek area have been tested for arsenic, it was not possible to accurately <br />delineate a study area based on that criterion. Instead, the study area delineation focused on a set of <br />addresses submitted to the North Carolina Central Cancer Registry by the Orange County Health <br />Department, which were used in a subsequent survey of homeowners. The initial study area <br />comprised of two Census Block Groups used by the Census Bureau for the 2000 U S. census, which <br />encompassed these addresses. The Census Bureau identifier numbers for these Block Groups are <br />1350108012 and 1350111012 (see attached exhibit). To garner input on the study area, the CCR <br />submitted this study area at an early stage in the analysis to the Orange County Health Department for <br />their review and the study area was finalized to include the two aforementioned Census Block Groups. <br />All bladder, liver, melanoma and Tung cancer cases were identified for the time period 1990-2003 in the <br />CCR database for Orange County, for cases whose city of residence at time of diagnosis was Mebane, <br />and all records for which the ZIP code at time of diagnosis was 27302. These records were geocoded <br />using a combination of county-maintained digital parcel-derived addresses, and vendor-maintained <br />digital street centerlines, The geocoding success rate was 98%, for records that had a geocodeable <br />street address. A rigorous attempt was made to geocode every record based on street address, city <br />and ZIP code, A total of 57 records were geocoded to within the study area. <br />The CCR has no residential, occupational or medical histories about cases, The CCR uses the <br />residence at the time of diagnosis as provided by the diagnosing facility to analyze cases by residence. <br />It is recognized that this may not be the relevant address in terms of etiology for a disease with a long <br />latency period, especially given the mobility of many populations. However, since we do not know at <br />what point the disease process that was later diagnosed as a malignant tumor actually began, it is not <br />possible to know what the relevant address is The focus of the CCR is on cancer surveillance, and <br />hence, we use the address at diagnosis. This approach is consistent with procedures used by all other <br />cancer registries in the United States including the National Cancer Institute's Surveillance, <br />Epidemiology and End Results (SEER) program, the North American Association of Central Cancer <br />Registries, and the Centers for Disease Control and Prevention. Incidence rates for a chronic disease <br />with a long latency period are useful for disease surveillance, but they may not be good indicators for <br />investigating the etiology of a disease. The CCR also uses the date of diagnosis as provided by the <br />reporting facility to determine in which year to classify each case, <br />Page .36 of 47 <br />